Both approaches are preferable to pushing through severe symptoms
E11.42 (polyneuropathy) E11.3212 (moderate NPDR, left eye, no macular edema) E11.12 (diabetic CKD stage 3) N18.3 (CKD stage 3, required companion) Z79.4 (long-term insulin, only Z79.4 needed when on both insulin and oral agents per official guidelines) Note: Z79.84 is NOT added here because per ICD-10-CM Official Guidelines, when a patient uses both insulin and oral hypoglycemics, only Z79.4 is assigned
Long-Term Use and Lifestyle Integration How Long Can You Stay on GLP-1 Medications
Most patients begin seeing weight loss within the first 46 weeks, especially when combined with simple dietary changes
CNS plasticity and cerebral glucose uptake are directly modulated by GLP-1 receptor activation [20, 21]
Some patients reach their optimal dose at the second level